A deal-data-grounded guide for medical waste business owners planning an exit. WM's $7.2B Stericycle acquisition anchors buyer demand — compliant haulers with healthcare MSAs and clean DOT/OSHA records command 7x–11x EBITDA.
Clayton G. Stiver, CPA
Managing Partner, Co-Founder · CPA · $1B+ Transaction Value
Enter your numbers and check what applies — see the multiple range and value range your business would likely command in today's market.
Calculation based on Ad Astra Equity transaction data.
Implied EBITDA margin: 17.8%
What lifts your multiple
What drags it down
Market Conditions
Why Medical Waste Companies Command Premium Multiples
Medical waste companies command some of the highest multiples in the waste services sector due to the non-discretionary, highly regulated nature of the service and the recurring revenue generated by long-term service agreements with healthcare facilities. The combination of regulatory compliance requirements, specialized handling infrastructure, and established healthcare relationships creates significant barriers to entry that protect established operators and support premium valuations.
The anchor event defining buyer demand in this category is WM's $7.2B acquisition of Stericycle, which closed November 4, 2024 — forming WM Healthcare Solutions . This transaction validated the premium buyers are willing to pay for compliant, recurring medical-waste infrastructure. Capstone Partners (Aug 2025) reports that while overall Waste & Recycling M&A activity declined 11.7% year-over-year to 98 transactions in YTD 2025, PE add-on activity rose to 54 deals from 51 — indicating quality-over-quantity buyer behavior that favors compliant operators with contracted healthcare accounts .
Compliant medical-waste haulers with autoclave or incinerator treatment access, healthcare system MSAs, and clean OSHA Bloodborne Pathogens Standard (29 CFR 1910.1030 ) and DOT 49 CFR Parts 171–180 records are the most sought-after assets in this category. The essential nature of the service — and the liability consequences for healthcare facilities that choose the wrong provider — creates strong customer loyalty and high switching costs that buyers value highly. EXTRAPOLATED: sub-$5M EBITDA compliant medical-waste haulers trade at 7x–11x EBITDA — at or slightly above solid-waste comps — because of federally regulated barriers to entry and customer stickiness comparable to specialty licensed services.
Want to know what YOUR medical waste business is worth?
Medical waste multiples sit at or above solid-waste comps due to the OSHA/DOT/EPA compliance moat. All figures are extrapolated from R1 Section 18 (solid waste primary data) plus the Stericycle valuation anchor.
Multiple range× EBITDA
4.5× EBITDABottom quartileSmall regional hauler, transport-only, treatment via third-party, limited healthcare MSA base (EXTRAPOLATED) [1][2]position: 0%
Top of market: Best-in-class medical waste platforms with owned autoclave or incinerator capacity, multi-state DOT registration, and hospital-system anchor accounts can clear 9x–11x EBITDA.
What lifts your multiple
Hospital and healthcare-system MSAs covering more than 50% of revenue
Owned or guaranteed-access autoclave or incinerator treatment capacity
Clean 36-month record across OSHA 29 CFR 1910.1030, DOT 49 CFR Parts 171–180, EPA RCRA
Owner replaceable with documented compliance manager and GM
Single hospital-system customer above 40% of total revenue
Owner as sole compliance officer — no documented compliance manager in place
Transport-only model with no owned or guaranteed treatment-facility access
Open OSHA, DOT, or EPA notices of violation in prior 36 months
Aging fleet with lapsed DOT HM-181 registration or expired container testing
What Drives Value
What Impacts the Value of Your Medical Waste Business
Buyers of medical waste businesses run compliance-first diligence before underwriting route economics. These six factors determine whether your business commands a specialty premium or a tuck-in discount.
High impact
Recurring service contracts
Recurring service contracts create predictable revenue and reduce customer churn risk, which buyers prioritize. Healthcare MSAs are the recurring-revenue spine; renewal rates and contracted-versus-spot mix drive the premium. A higher share of contracted revenue typically increases valuation multiples and can justify a higher offer price. For medical waste companies, buyers often pay a premium when 70%+ of revenue comes from signed multi-year agreements with hospital systems, dialysis centers, surgery centers, dental, and veterinary accounts — these relationships carry high switching costs and low attrition. EXTRAPOLATED: hospital-system MSAs above 50% of revenue add approximately 1.0x–2.0x EBITDA over a spot-pickup or small-quantity-only model.
High impact
Regulatory compliance record
A strong regulatory compliance record is the single most important asset in a medical waste transaction. OSHA Bloodborne Pathogens Standard (29 CFR 1910.1030 ), DOT 49 CFR Parts 171–180 hazardous-materials transport , EPA RCRA framework , and state-specific medical-waste statutes are the moat; any open notice of violation is a deal-killer or triggers material price chips. Before going to market, conduct a comprehensive compliance audit — any history of violations, spills, or permit issues will significantly reduce buyer interest. A clean 36-month record across all applicable regulatory frameworks is the defensive foundation that supports premium multiples. EXTRAPOLATED from R1 Section 18 compliance-moat logic.
High impact
Customer concentration
Customer concentration measures how dependent revenue is on a few accounts, and buyers care because losing one large generator can quickly reduce cash flow. Hospital-system concentration is common in medical waste but above 40% triggers earnout structures or material holdbacks. Buyers prefer diversification across hospitals, surgery centers, dialysis centers, dental, veterinary, and urgent care accounts — a diversified small-quantity generator base reduces single-customer concentration below the 40% threshold. In medical waste, buyers often penalize concentration above 40% with 1.0x–2.0x EBITDA discount or an earnout tied to top-customer retention.
High impact
Owner dependency
Owner dependency measures how much the business relies on you for sales, operations, compliance, and customer relationships, and buyers care because it increases transition risk. Owner-as-compliance-officer is a specific red flag in medical waste — if the owner holds the DOT safety officer or OSHA training coordinator role, buyers will discount for the regulatory transition risk. A documented compliance manager plus GM is worth 1.0x–2.0x EBITDA ; build this management depth 12–18 months before going to market to eliminate the key-person discount from your transaction.
Medium impact
Fleet and equipment condition
Fleet and equipment condition reflects reliability, compliance, and near-term capex needs, which buyers evaluate to reduce operational and regulatory risk. DOT-compliant fleet with current HM-181 registration, modern leak-proof containers, and treatment-tracking technology reduces deferred-capex haircuts and signals the operational standards WM Healthcare Solutions and Daniels Health buyers expect. IBBA Market Pulse Q3 2025 reports that clean equipment with no near-term replacement requirement is one of the top diligence accelerators across lower-middle-market service transactions . Prepare complete maintenance records, titles, and condition assessments for all collection vehicles and containers before engaging buyers.
Medium impact
Route density
Recurring, contract-based revenue matters because buyers want predictable cash flow and lower customer churn risk. In medical waste, route density — stops-per-route-hour and contracted-pickup-frequency economics — drives route profitability the same way it does in solid waste. For medical waste haulers, having 70%+ of revenue on 24–36 month auto-renewing agreements with healthcare facilities provides the contracted recurring-revenue foundation that supports premium multiples versus spot or on-call-only pickup models.
See where your business lands on these six factors in a free 15-minute call.
Four buyer types pursue medical waste businesses. The right positioning depends on your compliance record, treatment-capacity access, and healthcare customer mix — each buyer type underwrites these differently.
National waste consolidators
Waste Management Healthcare Solutions — formed through WM's $7.2B acquisition of Stericycle, which closed November 4, 2024 — is the dominant national buyer for compliant medical-waste operations. WM Healthcare Solutions pursues tuck-in acquisitions with recurring healthcare service contracts, clean DOT/OSHA/EPA compliance records, and routes that fill geographic density gaps in existing WM service areas. Structure typically runs 90–100% cash — these buyers bring public balance-sheet capital the same way WM, Republic, and WCN do in solid waste.
Typical deal size
$5M–$50M+ tuck-ins
Pay premium for
Healthcare MSA base, clean compliance record
Time to close
60–120 days
Healthcare services platforms
Daniels Health (privately held US and global medical-waste specialist) and MedPro Disposal are the named healthcare-specialty consolidators active in this segment. These buyers focus specifically on regulated medical waste (RMW), pharmaceutical waste, sharps, and pathological waste — and they pay for compliance-moat depth and healthcare-customer stickiness that generic waste haulers cannot replicate. Structure typically runs 80–90% cash with a modest rollover component to align post-close integration. EXTRAPOLATED from R3 Section 9 specialty-waste data.
Typical deal size
$2M–$25M EBITDA
Pay premium for
Specialty RMW capability, hospital-system anchors
Time to close
90–150 days
Private equity platforms
PE-backed medical-waste roll-up platforms pursue specialty add-ons in the $1–5M EBITDA range, building regional density through compliant operators with contracted healthcare accounts. The roll-up thesis mirrors solid waste — post-integration margin lift from standalone operations to integrated platform economics. These buyers typically require 5–10% equity rollover to align incentives. R3 does not name specific PE platforms for medical waste; keep this row generic based on sector analogs.
Typical deal size
$1M–$5M EBITDA
Pay premium for
Compliance moat, geographic density
Time to close
90–120 days
Search fund buyers
SBA and family-office buyers target sub-$2M EBITDA regional medical-waste operators with clean compliance records and reliable healthcare MSA bases. These buyers need SBA 7(a) financing or a meaningful seller note component, which constrains structure and timeline. They often offer more favorable cultural continuity for sellers prioritizing employee retention and legacy. Expect a longer close window and a higher proportion of seller-note financing versus the institutional buyer types.
Typical deal size
$500K–$2M EBITDA
Pay premium for
Clean compliance record, seller-stay willingness
Time to close
90–150 days
Get Ready
How to Prepare Your Medical Waste Business for Sale
Medical waste buyers lead with compliance diligence before underwriting route economics. These five steps, executed 6–12 months before going to market, protect your compliance premium and accelerate the close.
01
Maintain an exemplary compliance record
Medical waste is one of the most regulated service sectors — OSHA, DOT, EPA, and state environmental regulations all apply. Before going to market, conduct a comprehensive compliance audit covering OSHA 29 CFR 1910.1030 , DOT 49 CFR Parts 171–180 , and state medical-waste statutes. Any history of violations, spills, or permit issues will significantly reduce buyer interest — a clean compliance record is the single most important asset in a medical waste transaction. Target a clean 36-month record across all applicable frameworks before engaging buyers.
02
Document your service contract base
Prepare a complete schedule of all active service contracts — healthcare facilities, clinics, laboratories, and pharmaceutical clients — with annual contract value, service frequency, contract term, and renewal history. Long-term contracts with healthcare institutions are highly valued for their stability and non-discretionary nature. Separate recurring MSA revenue from on-call or spot-pickup revenue — buyers apply EXTRAPOLATED premium multiples to the recurring service revenue and need clear financial segmentation to value the business accurately.
03
Normalize your financials
Prepare 3–5 years of clean P&L statements with all owner add-backs documented. Separate recurring service contract revenue from equipment sales or one-time project work — buyers apply premium multiples to the recurring service revenue and need clear financial segmentation to value the business accurately. Owner compensation above market rate, personal vehicles, and one-time professional fees are standard add-backs; recurring capex items like fleet and container replacement are not.
04
Document disposal relationships and treatment capacity
Prepare documentation of all treatment facility relationships, disposal agreements, and capacity arrangements. Secure, compliant disposal capacity with documented agreements is a critical operational asset — buyers want confidence that autoclave or incinerator treatment infrastructure will be available post-close. If you own or have guaranteed access to treatment capacity, prepare the full permitting file — owned treatment infrastructure adds approximately 1.0x–1.5x EBITDA over a transport-only model (EXTRAPOLATED from R1 permit-moat logic).
05
Ensure all driver and technician certifications are current
DOT hazmat training certifications, state medical-waste handler licenses, and vehicle inspection records are closely scrutinized by buyers. Audit all certifications, document expiration dates, and address any gaps before engaging buyers. Driver and technician certification depth — particularly DOT HM-181 registration currency and OSHA bloodborne-pathogen training completion — is a meaningful competitive advantage and is evaluated alongside compliance history as a combined moat score in buyer diligence.
Illustrative Deal
What a Top-Quartile Medical Waste Exit Looks Like
Illustrative model only. Not representative of a current or past Ad Astra Equity client engagement. Figures are directional and based on representative market data.
The Business
A 14-year-old regional medical-waste hauler running 6 routes across 2 states, with 72% of revenue under hospital and healthcare-system MSAs and guaranteed-access treatment via third-party autoclave. Zero open OSHA, DOT, or EPA notices of violation in 36 months.
Compliance recordZero NOVs, 36-month clean OSHA/DOT/EPA record
Outcome
Enterprise value$13.6M
Multiple8.5x EBITDA
BuyerWM Healthcare Solutions tuck-in or healthcare-specialty platform (Daniels Health class)
Time to close105 days
Structure: 88% cash at close, 7% equity rollover, 5% earnout on top-10 customer retention
Why it worked
72% healthcare-system MSA mix provided the contracted recurring-revenue foundation that WM Healthcare Solutions and Daniels Health underwrite as their primary premium driver.
A clean 36-month compliance record across OSHA, DOT, and EPA eliminated the compliance-risk discount that is the most common deal-killer in this category.
Diversified small-quantity generator base — dental, vet, urgent care alongside hospital anchors — reduced single-customer concentration below the 40% earnout threshold.
From a recent client
What happens when you bring in the right advisor
Ad Astra ran a competitive process and we landed at a number I genuinely didn't think was on the table. They earned every dollar of their fee — and they don't ask for one until you close.
How Ad Astra Sells Medical Waste Businesses
Our Process
Ad Astra Equity advises medical waste owners through the full transaction lifecycle. We understand the compliance-first underwriting that WM Healthcare Solutions, Daniels Health, and PE specialty buyers run — and we position your compliance record, treatment access, and healthcare contracts to command the premium the category supports.
01
Discover & value
We analyze your healthcare MSA base, compliance record, treatment-capacity access, and route economics, then benchmark against recent medical and solid-waste transactions to give you a realistic value range before any market activity.
02
Position & document
We build the marketing materials, data room, and management presentation that highlight your compliance history, healthcare customer mix, treatment-infrastructure access, and route density to the right buyer pool.
03
Curated buyer outreach
We approach a targeted list of national waste consolidators (WM Healthcare Solutions), healthcare-specialty platforms (Daniels Health, MedPro Disposal), and qualified PE buyers under NDA — confidentiality is preserved throughout.
04
Negotiate & close
We manage the bid process, structure the deal to maximize cash at close, lead through compliance and treatment-infrastructure diligence, and shepherd the close — all on a success-only fee. You pay nothing until your deal closes.
FAQ
Common questions
Everything medical waste owners ask before going to market — from multiples and timing to deal structure and what we charge.
Compliant medical-waste haulers with sub-$5M EBITDA typically trade between 4.5x and 11.0x EBITDA, with the median around 6.5x–9.0x. All medical-waste specific multiples are extrapolated from solid-waste R1 data plus the specialty-premium implied by WM's $7.2B Stericycle acquisition. Where you land depends primarily on compliance record, healthcare MSA mix, treatment-capacity access, and customer concentration. A clean 36-month compliance record across OSHA, DOT, and EPA is the non-negotiable foundation for reaching the upper range.
